BUZZ-Tekmira Pharmaceuticals Corp: FDA puts early-stage study on hold
July 3 (Reuters) - ** Canadian drug developer's U.S.-listed shares down 17.5 pct at $11.38
** The U.S. Food and Drug Administration places on hold an early-stage study testing the company's experimental ebola drug in healthy volunteers
** FDA has asked for an amended protocol and additional data related to higher doses of the drug, Tekmira said
© Thomson Reuters 2017 All rights reserved.